• Alphamab Oncology repurchased 220,000 shares on Sept. 8 for treasury, no cancellations disclosed.
• Buyback price range HKD 8.35 to HKD 8.53; average price HKD 8.41.
• Total consideration HKD 1.85 million; issued shares excluding treasury fell to 967,665,697.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260908-12325032), on September 08, 2026, and is solely responsible for the information contained therein.